SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950129-04-000717
Filing Date
2004-02-20
Accepted
2004-02-19 18:30:44
Documents
1
Group Members
ESSEX WOODLANDS HEALTH VENTURES FUND IV, L.L.C.ESSEX WOODLANDS HEALTH VENTURES FUND IV, L.P.IMMANUEL THANGARAJJAMES L. CURRIEMARTIN P. SUTTER

Document Format Files

Seq Description Document Type Size
1 ESSEX WOODLANDS HEALTH VENTURES FUND IV, L.P. h12813sc13dza.txt SC 13D/A 20056
  Complete submission text file 0000950129-04-000717.txt   22191
Mailing Address
Business Address 201 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Subject) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-48459 | Film No.: 04617328
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10001 WOODLOCH FOREST DR STE 175 WOODLOCH TX 77380
Business Address 190 S LASALLE ST STE 2800 CHICAGO IL 60603
ESSEX WOODLANDS HEALTH VENTURES FUND IV L P (Filed by) CIK: 0001110080 (see all company filings)

IRS No.: 760573201 | State of Incorp.: DE | Fiscal Year End: 1231